These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8892930)

  • 1. Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.
    Orsini MJ; Debouck CM
    J Virol; 1996 Nov; 70(11):8055-63. PubMed ID: 8892930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of a potent HIV-2 Tat transdominant mutant protein.
    Echetebu CO; Rhim H; Herrmann CH; Rice AP
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):655-64. PubMed ID: 8207644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
    New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the amino and carboxy termini of the HIV-2 Tat protein.
    Echetebu CO; Rice AP
    J Acquir Immune Defic Syndr (1988); 1993 Jun; 6(6):550-7. PubMed ID: 8496787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
    Arya SK
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.
    Carroll R; Peterlin BM; Derse D
    J Virol; 1992 Apr; 66(4):2000-7. PubMed ID: 1312617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
    Ulich C; Harrich D; Estes P; Gaynor RB
    J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins.
    Fridell RA; Harding LS; Bogerd HP; Cullen BR
    Virology; 1995 Jun; 209(2):347-57. PubMed ID: 7778269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    J Virol; 1999 Jul; 73(7):5777-86. PubMed ID: 10364329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.
    Tong-Starksen SE; Baur A; Lu XB; Peck E; Peterlin BM
    Virology; 1993 Aug; 195(2):826-30. PubMed ID: 8337847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
    Song CZ; Loewenstein PM; Green M
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9357-61. PubMed ID: 7937769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication.
    Sadaie MR; Mukhopadhyaya R; Benaissa ZN; Pavlakis GN; Wong-Staal F
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1257-63. PubMed ID: 2078407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function.
    Yang X; Herrmann CH; Rice AP
    J Virol; 1996 Jul; 70(7):4576-84. PubMed ID: 8676484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis.
    Misumi S; Takamune N; Ohtsubo Y; Waniguchi K; Shoji S
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):297-304. PubMed ID: 15117453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of exon 2 in optimal trans-activation by Tat of HIV type 2.
    Pagtakhan AS; Tong-Starksen SE
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1367-72. PubMed ID: 8573394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
    Gatignol A; Duarte M; Daviet L; Chang YN; Jeang KT
    Gene Expr; 1996; 5(4-5):217-28. PubMed ID: 8723388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and functional characterization of wild-type and mutant HIV-1 and HIV-2 Tat proteins expressed in Escherichia coli.
    Orsini MJ; García-Martínez LF; Mavankal G; Gaynor RB; Debouck CM
    Protein Expr Purif; 1996 Sep; 8(2):238-46. PubMed ID: 8812870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.